MGMT and neoplasm: As a potential solution, rCBV was able to predict differences in IDH1 mutation and MGMT status,31 and tissue from hypercellular and hypervascular microfoci revealed greater expression of Ki‐67, HIF‐1a, CD31, and EGFR compared to tumor background.32